会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 51. 发明申请
    • USE OF CONKUNITZIN-S1 FOR THE MODULATION OF GLUCOSE-INDUCED INSULIN SECRETION
    • 用于调节葡萄糖诱导的胰岛素分泌的康宁嗪-S1
    • US20110224135A1
    • 2011-09-15
    • US13057809
    • 2009-08-10
    • Heinrich TerlauRocio Finol-UrdanetaStefan BeckerWalter Raasch
    • Heinrich TerlauRocio Finol-UrdanetaStefan BeckerWalter Raasch
    • A61K38/17C07K14/435C12Q1/02C07K1/107A61P3/10A61P3/04A61P3/00A61P9/12
    • C07K14/43504C07K14/8114
    • The present invention relates to a (poly)peptide or a peptidomimetic thereof having the biological activity of Conkunitzin-S1, wherein said (poly)peptide is selected from (a) a polypeptide comprising or having the amino acid sequence of SEQ ID NO: 1; (b) a polypeptide having at least 85% sequence identity to SEQ ID NO:1; or (c) a fragment of a) or b); wherein said (poly)peptide or peptidomimetic specifically modulates the activity of a channel having the activity of a Kv1.7 containing channel, for the treatment or prevention of metabolic diseases or conditions, or secondary diseases or conditions related to said metabolic diseases or conditions. The present invention furthermore relates to a method of screening for (poly)peptides derived from Conkunitzin-S1 suitable for specifically modulating the activity of a channel having the activity of a Kv1.7 containing channel, comprising: (a) altering the amino acid sequence of Conkunitzin-S1 represented by SEQ ID NO: 1 by deleting and/or inserting and/or replacing at least one amino acid; and (b) determining the modulatory effect of the (poly)peptide obtained in step (a) (i) on a channel having the activity of a Kv1.7 containing channel and (ii) on channels, preferably potassium channels, not having the activity of a Kv1.7 containing channel, which are optionally expressed on the same cell as the channel having the activity of a Kv1.7 containing channel.
    • 本发明涉及具有Conkunitzin-S1生物活性的(多)肽或其肽模拟物,其中所述(多)肽选自(a)包含或具有SEQ ID NO:1的氨基酸序列的多肽 ; (b)与SEQ ID NO:1具有至少85%序列同一性的多肽; 或(c)a)或b)的片段; 其中所述(多)肽或肽模拟物特异性调节具有Kv1.7含有通道活性的通道的活性,用于治疗或预防代谢疾病或病症,或与所述代谢疾病或病症有关的继发性疾病或病症。 本发明还涉及一种筛选衍生自Conkunitzin-S1的(多)肽的方法,其适用于特异性调节含有Kv1.7含有通道活性的通道的活性,其包括:(a)改变氨基酸序列 通过删除和/或插入和/或替换至少一个氨基酸的由SEQ ID NO:1表示的Conkunitzin-S1; (b)确定步骤(a)(i)中获得的(多)肽对具有Kv1.7含有通道活性的通道的调节作用,和(ii)在不具有 包含Kv1.7的通道的活性,其任选地在与具有含有Kv1.7的通道的活性的通道相同的单元上表达。
    • 59. 发明授权
    • Method for handling phone numbers in mobile station and mobile station
    • 移动台和移动台处理电话号码的方法
    • US06606508B2
    • 2003-08-12
    • US09141062
    • 1998-08-27
    • Stefan BeckerJuha Kurkilahti
    • Stefan BeckerJuha Kurkilahti
    • H04B138
    • H04M19/041H04M1/57H04M1/663H04M1/72519
    • The invention relates to a method for handling phone numbers in a mobile station and a mobile station. According to the invention, numbers (3a, 3b, 3c) are handled in groups (1a, 1b, 1c) which have different attributes (2a, 2b, 2c). The attributes (2a, 2b, 2c) mean e.g. rights to generate a ringing tone. In a certain operating mode, only a call belonging to a group (1a, 1b, 1c) which in that operating mode has the right to call the mobile station, will generate a ringing tone. The attributes (2a, 2b, 2c) also mean group-specific ringing tones which represent the type of the group (1a, 1b, 1c). The attributes (2a, 2b, 2c) further mean symbols on the display of a mobile station.
    • 本发明涉及一种在移动台和移动台中处理电话号码的方法。 根据本发明,数字(3a,3b,3c)以具有不同属性(2a,2b,2c)的组(1a,1b,1c)处理。 属性(2a,2b,2c)表示例如。 生成铃声的权利。 在某种操作模式中,只有在该操作模式中有权呼叫移动台的组(1a,1b,1c)的呼叫将产生振铃音。 属性(2a,2b,2c)也表示代表组(1a,1b,1c)的类型的组专用振铃音。 属性(2a,2b,2c)还表示移动台的显示上的符号。